Clinical Trials

Showing trials with last updates posted in 2023.

NCT02869633 | COMPLETED | PHASE2
23 participants

Ibrutinib in Treating Patients With Refractory or Relapsed Lymphoma After Donor Stem Cell Transplant

Study Type:
INTERVENTIONAL
Last Updated:
2023-10-23
Start Date:
2016-11-30
Completion:
2021-11-18
Conditions
  • Blastoid Variant Mantle Cell Lymphoma
  • Recurrent Chronic Lymphocytic Leukemia
  • Recurrent Follicular Lymphoma
  • Recurrent Hodgkin Lymphoma
  • Recurrent Mantle Cell Lymphoma
  • Refractory Chronic Lymphocytic Leukemia
  • Refractory Follicular Lymphoma
  • Refractory Hodgkin Lymphoma
  • Refractory Mantle Cell Lymphoma
Interventions
  • DRUG
  • OTHER
NCT02657837 | RECRUITING
300 participants

Measures of Respiratory Health (MRH)

Study Type:
OBSERVATIONAL
Last Updated:
2023-10-23
Start Date:
2016-01-31
Completion:
2024-12-01
Conditions
  • Cystic Fibrosis
  • Asthma
  • Sickle Cell Anemia
  • Bronchiolitis Obliterans
No Results Yet
NCT01366833 | TERMINATED | NA
3 participants

Optimal Management of Malignant Dysphagia

Study Type:
INTERVENTIONAL
Last Updated:
2023-10-23
Start Date:
2011-06-30
Completion:
2017-03-31
Conditions
  • Malignant Dysphagia
  • Esophageal Cancer
Interventions
  • RADIATION
  • PROCEDURE
No Results Yet
NCT00611351 | COMPLETED | PHASE2
5 participants

Busulfan, Cyclophosphamide, & Antithymocyte Globulin Followed by Stem Cell Transplant in Treating Hematologic Cancer

Study Type:
INTERVENTIONAL
Last Updated:
2023-10-23
Start Date:
2005-06-07
Completion:
2008-02-01
Conditions
  • Graft Versus Host Disease
  • Leukemia
  • Lymphoma
  • Multiple Myeloma and Plasma Cell Neoplasm
  • Myelodysplastic Syndromes
  • Myelodysplastic/Myeloproliferative Diseases
  • Secondary Myelofibrosis
Interventions
  • BIOLOGICAL
  • DRUG
  • GENETIC
  • OTHER
  • PROCEDURE
Previous
Sorted by latest updates
Next
Showing 40 trials per page